venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 7
- 0 vs. Q4 2024
- Portfolio value
- $123.6M
- −$47.2M (−27.6%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PHVSPharvaris N.V. | COM | 4,289,304 | $67.3M | 54.5% | 00.0% | Unchanged | History |
| ALMSAlumis Inc. | COM | 2,787,398 | $17.1M | 13.9% | 00.0% | Unchanged | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 489,194 | $16.2M | 13.1% | −50,000−9.3% | Reduced | History |
| SLRNACELYRIN, Inc. | COM | 3,806,410 | $9.40M | 7.6% | 00.0% | Unchanged | History |
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $6.04M | 4.9% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM | 7,102,190 | $3.82M | 3.1% | 00.0% | Unchanged | History |
| ARTVArtiva Biotherapeutics, Inc. | COM | 1,198,975 | $3.60M | 2.9% | −320,996−21.1% | Reduced | History |